{"id":289833,"date":"2025-12-15T16:40:08","date_gmt":"2025-12-15T16:40:08","guid":{"rendered":"https:\/\/www.europesays.com\/es\/289833\/"},"modified":"2025-12-15T16:40:08","modified_gmt":"2025-12-15T16:40:08","slug":"los-resultados-del-estudio-fase-3-majestec-3-respaldan-la-formulacion-subcutanea-de-%e2%96%bctecvayli-teclistamab-en-combinacion-con-darzalex-daratumumab-revista-pharma-market","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/es\/289833\/","title":{"rendered":"Los resultados del estudio fase 3 MajesTEC-3 respaldan la formulaci\u00f3n subcut\u00e1nea de \u25bcTECVAYLI\u00ae (teclistamab) en combinaci\u00f3n con DARZALEX\u00ae (daratumumab) – Revista Pharma Market"},"content":{"rendered":"
    \n
  1. Los resultados del estudio fase 3 MajesTEC-3 respaldan la formulaci\u00f3n subcut\u00e1nea de \u25bcTECVAYLI\u00ae (teclistamab) en combinaci\u00f3n con DARZALEX\u00ae (daratumumab)<\/a>  Revista Pharma Market<\/li>\n
  2. La nueva terapia que aumenta la supervivencia en un c\u00e1ncer de sangre que no responde al tratamiento<\/a>  El Confidencial<\/li>\n
  3. La combinaci\u00f3n de 2 f\u00e1rmacos revoluciona la pr\u00e1ctica cl\u00ednica para mielomas<\/a>  Redacci\u00f3n M\u00e9dica<\/li>\n
  4. Estar tres a\u00f1os con mieloma m\u00faltiple sin empeorar ya es posible<\/a>  La Raz\u00f3n<\/li>\n
  5. Una nueva terapia con anticuerpos erradica el mieloma m\u00faltiple en 18 pacientes<\/a>  diariodesalud.com.do<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Los resultados del estudio fase 3 MajesTEC-3 respaldan la formulaci\u00f3n subcut\u00e1nea de \u25bcTECVAYLI\u00ae (teclistamab) en combinaci\u00f3n con DARZALEX\u00ae…\n","protected":false},"author":2,"featured_media":286036,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[80],"tags":[82,95,94,25,24,23],"class_list":{"0":"post-289833","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-economia","8":"tag-business","9":"tag-economia","10":"tag-economy","11":"tag-es","12":"tag-espana","13":"tag-spain"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/posts\/289833","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/comments?post=289833"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/posts\/289833\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/media\/286036"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/media?parent=289833"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/categories?post=289833"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/tags?post=289833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}